Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBC.1.3.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.208EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.208EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.197EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.197EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.491EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.491EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EV.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EV.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
P.1.8 (Gamma)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
P.1.8 (Gamma)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.39.3 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-3064.43China
AY.39.3 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-3384China
B.1.1.95EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.95EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.36.26EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.36.26EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.531EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.531EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.45EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.45EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.200EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.200EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.299EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.299EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.125EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.125EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
G.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
G.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.438EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.438EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.35EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.35EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.178EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.178EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XAY.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XAY.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.16.5EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.16.5EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.60EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.60EHuang-EGCAGCAGTACGCACACAATC20552637626357R-5161.21China
FH.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FH.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CJ.1.3EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CJ.1.3EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.32EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.32EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.26.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.26.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used